US6365216B1 - Particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester - Google Patents

Particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester Download PDF

Info

Publication number
US6365216B1
US6365216B1 US09/534,067 US53406700A US6365216B1 US 6365216 B1 US6365216 B1 US 6365216B1 US 53406700 A US53406700 A US 53406700A US 6365216 B1 US6365216 B1 US 6365216B1
Authority
US
United States
Prior art keywords
aspartyl
dimethylbutyl
phenylalanine
methyl ester
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US09/534,067
Inventor
Aditi Dron
Ihab E. Bishay
Jim Fotos
Michael J. Trione
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NUTRASWEET PROPERTY HOLDINGS Inc
Bank of America NA
Original Assignee
Nutrasweet Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US09/534,067 priority Critical patent/US6365216B1/en
Assigned to NUTRASWEET COMPANY, THE reassignment NUTRASWEET COMPANY, THE ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BISHAY, IHAB E., DRON, ADITI, FOTOS, JIM, TRIONE, MICHAEL J.
Application filed by Nutrasweet Co filed Critical Nutrasweet Co
Assigned to BANKERS TRUST COMPANY reassignment BANKERS TRUST COMPANY SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NUTRASWEET COMPANY, THE
Application granted granted Critical
Publication of US6365216B1 publication Critical patent/US6365216B1/en
Assigned to NUTRASWEET COMPANY, THE reassignment NUTRASWEET COMPANY, THE RELEASE OF SECURITY INTEREST IN U.S. PATENTS Assignors: DEUTSCHE BANK TRUST COMPANY AMERICAS (F/K/A BANKERS TRUST COMPANY), AS AGENT
Assigned to GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT reassignment GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NUTRASWEET COMPANY, THE
Assigned to GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT reassignment GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT SECURITY AGREEMENT Assignors: NUTRASWEET COMPANY, THE
Assigned to GENERAL ELECTRIC CAPITAL CORPORATION AS SECOND LIEN AGENT reassignment GENERAL ELECTRIC CAPITAL CORPORATION AS SECOND LIEN AGENT SECOND LIEN PATENT SECURITY AGREEMENT Assignors: NUTRASWEET COMPANY, THE
Assigned to NUTRASWEET COMPANY, THE reassignment NUTRASWEET COMPANY, THE RELEASE OF SECURITY INTEREST IN PATENTS RECORDED 10/15/2004 WITH USPTO AT REEL 015302 FRAME 0536. Assignors: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Assigned to NUTRASWEET COMPANY, THE reassignment NUTRASWEET COMPANY, THE RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: GENERAL ELECTRIC CAPITAL CORPORATION, AS SECOND LIEN AGENT
Assigned to BANK OF AMERICA, N.A., AS AGENT reassignment BANK OF AMERICA, N.A., AS AGENT SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NUTRASWEET COMPANY, THE
Assigned to BANK OF AMERICA, N.A., AGENT reassignment BANK OF AMERICA, N.A., AGENT COLLATERAL ASSIGNMENT OF PATENTS Assignors: THE NUTRASWEET COMPANY
Assigned to NUTRASWEET PROPERTY HOLDINGS, INC. reassignment NUTRASWEET PROPERTY HOLDINGS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: THE NUTRASWEET COMPANY
Assigned to THE NUTRASWEET COMPANY reassignment THE NUTRASWEET COMPANY RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: BANK OF AMERICA, N.A.
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A23L27/31—Artificial sweetening agents containing amino acids, nucleotides, peptides or derivatives
    • A23L27/32—Artificial sweetening agents containing amino acids, nucleotides, peptides or derivatives containing dipeptides or derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents

Definitions

  • This invention relates to the formation of particles of N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-L-phenylalanine 1-methyl ester (neotame) by, for example, extrusion and/or spheronization with and without binders.
  • Neotame is converted from a light powder to dustless, free-flowing particles suitable for use in a variety of applications.
  • This invention also relates to food products sweetened with the neotame particles, as well as to methods of preparing such food products.
  • N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-phenylalanine 1-methyl ester is an extremely potent sweetening agent (about 8000X sweeter than sugar) that has the formula
  • Extrusion is a well known technique used in a number of industries for a variety of purposes. For example, food compositions are routinely extruded in order to obtain desired shapes and forms; similarly, other materials such as agricultural compositions and plastics are extruded. In addition, extrusion apparatuses can be used as delivery means for a wide range of products.
  • Spheronization is a well known technique used in the pharmaceutical industry to provide rounded particles that can be uniformly coated.
  • WO 95/22319 discloses a process for preparing fine particle pharmaceutical formulations by combining dry components with an extrusion aid (typically a pharmaceutically acceptable oil or wax), wetting the mixture, extruding and then spheronizing. This procedure results in fine particle formulations which exhibit improved uniformity of particle size and performance characteristics such as drug release.
  • an extrusion aid typically a pharmaceutically acceptable oil or wax
  • WO 93/07859 generally discloses a method of preparation for pharmaceutical pellets comprising melt spheronization, i.e., extrusion under temperatures appropriate to melt the active pharmaceutical agent and necessary excipients and subsequent spheronization.
  • WO 89/00819 discloses self-stabilized compositions of dipeptide sweeteners and their salts and complexes, which exhibit heat stability and a sustained release mechanism that insures uniform dissolution and dispersion within baked products.
  • the compositions are produced by spheronizing a dipeptide sweetener, aspartame in particular, with or without a suitable binding agent to produce dense, non-porous spherical granules of narrow particle size distribution.
  • the compositions may be coated with a hydrophobic coating.
  • the present invention is directed to a process for forming particles of N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-L-phenylalanine 1-methyl ester.
  • This process comprises the steps of (a) mixing N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-L-phenylalanine 1-methyl ester and a plasticizer to form a wet mass; (b) extruding said wet mass to form extrudates; and (c) drying said extrudates to form said particles of N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-L-phenylalanine 1-methyl ester.
  • water is used as the plasticizer.
  • a binder is incorporated in the wet mass prior to the extruding step.
  • the wet mass is heated prior to the extruding step.
  • spheres are formed from the extrudates prior to drying.
  • This invention is further directed to extruded or spheronized particles of N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-L-phenylalanine 1-methyl ester made according to the processes of the present invention.
  • Additional embodiments of the present invention are directed to food products sweetened with such particles of neotame and to methods of sweetening food products with the particles of neotame of this invention such as extruded neotame, spheronized neotame or the like.
  • N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-L-phenylalanine 1-methyl ester is a high potency dipeptide sweetener (about 8000X sweeter than sucrose) that has the formula
  • N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-L-phenylalanine 1-methyl ester exists as a light, somewhat dusty powder.
  • Extrusion and optional spheronization can be used as particle formation techniques to form relatively dustless, free flowing particles of N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-L-phenylalanine 1-methyl ester.
  • Such particles can be regarded as “extrudates” or “spheres”, depending upon their processing and characteristics.
  • the term “particles” includes, for example, “granules” such as “extrudates”, “spheres” and the like, which have been, for example, “granulated”, (e.g., “extruded”, “spheronized” or the like).
  • the terms “extrudates” or “extruded neotame” refer to preferably cylindrical, free-flowing, relatively non-dusty, mechanically strong granules of N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-L-phenylalanine 1-methyl ester.
  • spheres or “spheronized neotame” refer to relatively spherical, smooth, free-flowing, relatively non-dusty, mechanically strong granules. While spheres typically have a smoother surface and may be stronger/harder than extrudates, extrudates offer a cost advantage in that less processing is required.
  • the spheres and extrudates of this invention may be further processed, if desired, to form various other particles, such as, for example, by grinding or chopping.
  • neotame Any form of neotame may be used in the extrudates and spheres of this invention.
  • salts and metal complexes of neotame may be used, such as disclosed in U.S. Pat. No. 6,291,004, U.S. Pat. No. 6,180,156, U.S. Pat. No. 6,129,942, and U.S. Pat. No. 6,146,680, all filed Sep. 4, 1998, and all of which are incorporated by reference herein.
  • the anhydrous form of neotame is suitable for use in this invention, as well as the various crystalline forms of neotame.
  • One embodiment of the present invention is directed to a process by which particles of N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-L-phenylalanine 1-methyl ester are formed with the use of a binder.
  • N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-L-phenylalanine 1-methyl ester, a plasticizer and a binder are mixed to form a wet mass.
  • Suitable plasticizers include, without limitation, water, glycerol and mixtures thereof. Water is a particularly preferred plasticizer.
  • Suitable binders include, without limitation, polyvinylpyrollidone (PVP), maltodextrins, microcrystalline cellulose, starches, hydroxypropylmethyl cellulose (HPMC), methylcellulose, hydroxypropyl cellulose (HPC), gum arabic, gelatin, xanthan gum and mixtures thereof.
  • the binder is generally present in the wet mass in an amount of about 0.01-45% by weight, and preferably from 0.5-10% by weight.
  • Binder can optionally be dissolved in the plasticizer to form a binder solution.
  • the binder solution can then be added to the neotame and other dry ingredients if present. In this way, the binder will be better distributed throughout the wet mass. If this is done using an extruder that has mixing capability (e.g., Extrud-O-Mix by Hosokawa Bepex), then the binder solution could be continuously added and mixed into the dry ingredients. This would help to eliminate the mixing/kneading step and also the need for mixing/kneading equipment.
  • N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-L-phenylalanine 1-methyl ester is generally present in the wet mass in an amount of about 0.5-90% by weight, and preferably from about 1-80% by weight.
  • the plasticizer is generally present in the wet mass in an amount of 4-45% by weight, and preferably from 15-35% by weight.
  • any typical food ingredient may be incorporated in the wet mass as a carrier or as an additive; one of ordinary skill in this art would readily appreciate the scope of appropriate food ingredients, as well as the acceptable amount of a given food ingredient to incorporate in the wet mass.
  • lactose, maltodextrins, dextrose, citric acid, microcrystalline cellulose, sugar, sugar alcohols and mixtures thereof are included in the wet mass as a carrier.
  • CaCl 2 , MgCl 2 , flavor enhancers/modifiers, acidulants and mixtures thereof are included in the wet mass as additives.
  • Appropriate amounts, as readily determined by one of ordinary skill in the art, of such carriers and additives can be included in the wet mass in order to achieve a desired effect on taste or functionality.
  • the wet mass is extruded to form extrudates.
  • Extrusion can be accomplished by any known means, including a low pressure extruder fitted with a die. One skilled in the art can readily choose an appropriate die size in order to obtain the desired final particle size.
  • the wet extrudates can be further cut into uniform length pellets using a cutting device attached to the discharge end of the extruder.
  • the extrudates are preferably cylindrical in shape and usually take the form of noodles or pellets.
  • the shape and size of the extrudates may vary depending upon the shape and size of the die openings and the use of a cutting device.
  • the extrudates are dried. Drying is generally accomplished using a fluidized bed dryer, though any suitable drying method may be employed.
  • the extrudates are formed into spheres prior to drying, typically by charging into a marumerizer.
  • a marumerizer consists of a vertical hollow cylinder (bowl) with a horizontal rotating disc (friction plate) therein.
  • the noodle-like extrudates are charged onto the friction plate and almost immediately break into short segments of uniform length.
  • the rotating disc surface can have a variety of textures suited for specific purposes. Typically a grid is applied, the pattern of which corresponds to the desired particle size.
  • the plastic extrudate segments are formed into spheres by contact with the rotating disc as well as by collisions with the wall and between particles. During deformation into spheres and densification, excess moisture may move to the surface or thixotropic behavior may be exhibited by the mass. When this happens, slight dusting with a suitable powder dispenser reduces the probability that particles will stick together.
  • a second embodiment of the present invention is directed to a process by which particles of N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-L-phenylalanine 1-methyl ester are formed without the use of a binder.
  • N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-L-phenylalanine 1-methyl ester unlike other known high potency sweeteners, exhibits unique binding properties at the temperatures of the present process. This may be due, in part, to neotame's low melting point (82° C.).
  • the formation of particles without having to use a binder is desirable as it lowers costs and increases product quality. In this way, it is possible to make particles which do not contain any additives. Further, because it is also possible to make compositions having very high neotame concentrations, flexibility in delivering neotame for targeted uses is provided.
  • N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-L-phenylalanine 1-methyl ester and a plasticizer are mixed to form a wet mass. This can be done in a kneader/continuous mixer.
  • Suitable plasticizers include, without limitation, water, glycerol and mixtures thereof. Water is a particularly preferred plasticizer.
  • N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-L-phenylalanine 1-methyl ester is generally present in the wet mass in an amount of 65-85% by weight.
  • the plasticizer is generally present in the wet mass in an amount of 15-35% by weight.
  • the wet mass is heated to promote the binding of the wet mass.
  • the wet mass is heated to approximately 30° C. to 65° C., and preferably from 40° C. to 60° C. Such heating may be performed in an oven or in a kneader with heated jacket.
  • both the above-mentioned steps i.e., mixing and heating, can be accomplished in an extruder that has mixing capabilities and can provide heating either by high shear or by the use of a heating jacket.
  • the wet mass is extruded to form extrudates, and the extrudates or spheres are dried.
  • spheres are formed from the extrudates prior to drying, typically by charging them into a marumerizer.
  • the wet mass of the present inventive processes can take the form of neotame wetcake, an intermediate stage in the production of neotame.
  • neotame wetcake directly into particles which are non-dusty, free-flowing, value-added forms rather than drying the wetcake into neotame powder and then re-wetting the powder to form the wet mass of the present inventive processes.
  • This processing approach will eliminate one drying step and will reduce the processing cost for the manufacture of neotame particles.
  • the N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-L-phenylalanine 1-methyl ester particles (extrudates or spheres) of this invention typically have a particle size ranging from about 10 to about 140 mesh. Preferably, the particles have a particle size ranging from about 20 to about 80 mesh.
  • the amount of N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-L-phenylalanine 1-methyl ester is generally from about 25% to about 99.9% and preferably from about 80% to about 99% and most preferably from about 84% to about 96.7% by weight of the particles.
  • the amount of plasticizer is generally from about 0% to about 15% and preferably from about 3% to about 6% by weight of the particles.
  • the amount of binder present in the final neotame particles is generally from about 0.1% to about 60% and preferably from about 0.1% to about 10% by weight of the particles.
  • the amount of N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-L-phenylalanine 1-methyl ester is generally from about 85% to about 100% and preferably from about 94% to about 97% by weight of the particles.
  • the amount of plasticizer is generally from about 0% to about 15% and preferably from about 3% to about 6% by weight of the particles.
  • neotame particles of this invention may be coated/encapsulated to increase heat stability, etc.
  • Suitable encapsulants include, without limitation, carbohydrates (e.g., starches, gums, maltodextrins, cyclodextrins), proteins (e.g., zein), fats and waxes, sugars, polymers (e.g., polyvinylacetate, polyethylene), hydroxypropylmethyl cellulose and mixtures thereof.
  • the extruded or spheronized N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-L-phenylalanine 1-methyl ester of this invention is suitable for use in any food to supplement or replace natural sweeteners, as well as other high intensity sweeteners, normally used as sweeteners.
  • the term food as used herein includes, for example, beverages, fluid dairy products, non-dairy products, condiments, baked goods, frostings, bakery fillings, candy and chewing gum.
  • the extruded or spheronized N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-L-phenylalanine 1-methyl ester may also be used in table top sweeteners.
  • Beverages include, without limitation, carbonated soft drinks, including cola, lemon-lime, root beer, heavy citrus, fruit flavored and cream sodas; powdered soft drinks, as well as liquid concentrates such as fountain syrups and cordials; coffee and coffee-based drinks, coffee substitutes and cereal-based beverages; teas, including dry mix products as well as ready-to-drink teas (herbal and tea-leaf based); fruit and vegetable juices and juice flavored beverages as well as juice drinks, nectars, concentrates, punches and “ades”; sweetened and flavored waters, both carbonated and still; sport/energy/health drinks; alcoholic beverages plus alcohol-free and other low-alcohol products including beer and malt beverages, cider, and wines (still, sparkling, fortified wines and wine coolers); other beverages processed with heating (infusions, pasteurization, ultra high temperature, ohmic heating or commercial aseptic sterilization) and hot-filled packaging; and cold-filled products made through filtration or other preservation techniques.
  • carbonated soft drinks including
  • Fluid dairy products include, without limitation, non-frozen, partially frozen and frozen fluid dairy products such as, for example, milks, ice creams, cultured dairy products such as yogurts and the like.
  • Non-dairy products include, for example, sorbets.
  • Condiments include, without limitation, ketchup, mayonnaise, salad dressing, Worcestershire sauce, fruit-flavored sauce, chocolate sauce, tomato sauce, chili sauce, and mustard.
  • Baked goods include, without limitation, cakes, cookies, pastries, breads, donuts and the like.
  • Bakery fillings include, without limitation, low or neutral pH fillings, high, medium or low solids fillings, fruit or milk based (pudding type or mousse type) fillings, hot or cold make-up fillings and non-fat to full-fat fillings.
  • This invention is also directed to a sweetened food composition, such as described above, containing an effective amount of the N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-L-phenylalanine 1-methyl ester particles of this invention (e.g., extruded or spheronized neotame) to sweeten the food composition.
  • an effective amount of the N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-L-phenylalanine 1-methyl ester particles of this invention e.g., extruded or spheronized neotame
  • Determination of the amount of neotame particles to be added to the food composition can be readily determined by one of ordinary skill in the art.
  • the particles of neotame (e.g., extruded or spheronized neotame) of the present invention can be used for this purpose alone or in combination with known bulking agents.
  • Suitable bulking agents include, but are not limited to, dextrose, maltodextrin, lactose, inulin, polyols, polydextrose, cellulose and cellulose derivatives and organic acids including, but not limited to, citric acid and malic acid.
  • Such a product may be suitable for use especially for table-top sweeteners and powdered soft drinks.
  • a table-top sweetener comprising the present particles of neotame may also include any other ingredients commonly present in table-top sweeteners in order to tailor the taste of the product to a specific end use.
  • a table-top sweetener comprising the present particles of neotame may take any known form. Suitable forms include, but are not limited to, sachets including the sweetener in powder or granular form, tablets, liquid sweeteners, and jar, pouches, pocket or other forms in which the sweetener may be measured in, for example, spoon for spoon form.
  • the particles of N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-L-phenylalanine 1-methyl ester e.g., extruded or spheronized neotame
  • N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-L-phenylalanine 1-methyl ester e.g., extruded or spheronized neotame
  • Sweeteners that may be employed include, without limitation, aspartame, acesulfame salts (e.g., acesulfame-K), sucralose, saccharin, alitame, cyclamates, stevia derivatives, thaumatin, sucrose (liquid and granulated), high fructose corn syrup, high conversion corn syrup, crystalline fructose, glucose (dextrose), polyol sugar alcohols, invert sugar and mixtures thereof.
  • any of these known natural sweeteners or other high intensity sweeteners may be combined with neotame, the plasticizer and the optional binder in the present inventive processes to form the wet mass.
  • N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-L-phenylalanine 1-methyl ester (75 wt %) and water (25 wt %) were manually mixed and kneaded.
  • This dough was pre-heated in an oven and extruded at 40° C. using 0.8 mm die. Very good, smooth extrudates were obtained at a high rate. These extrudates were processed in a marumerizer for 30 seconds to form spheres. The spheres were dried in a fluid bed dryer at 50° C. Spherical particles were obtained without any clumps, fines or dust. The spheres did not disintegrate even after shipping.
  • the moisture content of the particles was 5.2% as measured using Karl Fischer titration.
  • the dissolution rate of the particles was: 670 ppm totally dissolved in 20° C. water in 5 minutes.
  • the neotame assay conducted on the particles showed that it survived the process with minimal formation of degradants.
  • N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-L-phenylalanine 1-methyl ester (80 wt %), water (15 wt %) and polyvinylpyrollidone (5 wt %) were manually mixed and kneaded.
  • the mixture was extruded using a low pressure extruder with a 0.8 mm die (model DG-L1, LCI).
  • the extrudates were spheronized in a marumerizer (model QJ-400, LCI) for 30 seconds, resulting in good spheres with no clumps. These spheres were dried in a fluid bed dryer at 50° C. The spheres did not disintegrate in the dryer.
  • the moisture content of the spherical particles was 5.1%, as measured using Karl Fischer titration.
  • the dissolution rate of the particles was: 670 ppm totally dissolved in 20° C. water in 1.5 minutes. The neotame assay conducted on the particles showed that it survived the process with minimal formation of degradants.
  • Examples 3-7 were prepared in a manner substantially similar to Example 2, except the components employed differed as shown in Table 1 below.
  • hardness was tested in the following manner. Approximately 75 g particulate material was screened on an 80 mesh screen. The material was shaken using a Ro-Tap® Testing Sieve Shaker (model B, C. E. Tyler Combustion Engineering Inc.) for ten minutes with a hammer. About 50 ⁇ 1 g of material retained on the screen was transferred to the pan of the screen assembly. Ten 0.5′′ steel balls were placed in the pan, and clean 80 mesh screen was positioned above the pan. The Ro-Tap® shaker was run for another ten minutes without the hammer. The assembly was removed from the shaker, and the steel balls were removed from the pan. The material was transferred from the pan to the 80 mesh screen.
  • Ro-Tap® Testing Sieve Shaker model B, C. E. Tyler Combustion Engineering Inc.
  • dissolution rate The dissolution rate of each sample was measured as a function of absorbance at 258 nm using a spectrophotometer. Sample (0.1 g) was added to 150 g deionized water at 20° C. The water was stirred, and absorbance was measured versus time until it reached its highest value and became constant. The time required to reach the highest level of absorbance has been reported as “dissolution rate”.
  • N-[N-(3,3-dimethylbutyl)-L- ⁇ -aspartyl]-L-phenylalanine 1-methyl ester (80 wt %), water (15 wt %) and polyvinylpyrollidone (5 wt %) were manually mixed and kneaded.
  • the mixture was extruded using a low pressure extruder with a 0.8 mm die (model DG-L1, LCI).
  • the extrudates were dried in a fluid bed dryer at 50° C.
  • the Karl Fischer moisture content, dissolution rate and hardness for these cylindrical particles with rounded edges were determined via the same methods outlined in Examples 3-7 above. Specifically, the moisture content was 5.3%, the dissolution rate was 1.5 min and the hardness was 75.3%.
  • Neotame wetcake containing 31.2% moisture was fed to an extruder (Extrud-O-Mix, model EM-2, single screw, axial, low pressure, Hosokawa Bepex) through the screw feeder.
  • Wet extrudates were smooth but long and warm; some of the extrudates stuck together. They were screened manually using an 8 mesh screen to break up the larger agglomerates and then dried in a fluid bed dryer with inlet air temperature at 62° C. It was dried until the outlet air temperature rose to 52° C. No breakage of particles was observed during drying.
  • the dried extrudates contained 2.1% moisture (tested using Karl Fischer titration). Dissolution rate was determined to be 15 minutes using the UV absorbance method described in connection with Examples 3-7. Hardness was 92.9%, as measured in the same manner as in Examples 3-7.
  • Sweetener blends were formed using extrusion. Extrudates were prepared in a manner substantially similar to Example 8, except the components employed differed as shown in Table 3. All extrudates were formed using the same extruder (Extrud-O-Mix, EM-2, Hosokawa Bepex). All extrudates were dried using STREA-1 (Aeromatic).
  • Methocel K3 Premium, Methocel E3 Premium, Methocel E15 Premium and Methocel K35 were used to form extrudates as set forth in Table 4.
  • the main difference between these grades is their viscosity in water solution.
  • K3 and E3 have the lowest, E15 has intermediate and K35 has the highest viscosity.
  • An EXD-60 extruder (LCI) was used for extrusion.
  • STREA-1 fluid bed dryer (Aeromatic) was used for drying the wet extrudates.

Abstract

N-[N-(3,3-dimethylbutyl)-L-alpha-aspartyl]-L-phenylalanine 1-methyl ester is converted from a light powder to relatively dustless, free-flowing particles with and without the use of binders using extrusion and spheronization processes. These particles are suitable for use in a variety of applications. Food products sweetened with extruded or spheronized N-[N-(3,3-dimethylbutyl)-L-alpha-aspartyl]-L-phenylalanine 1-methyl ester and methods of sweetening food products with such N-[N-(3,3-dimethylbutyl)-L-alpha-aspartyl]-L-phenylalanine 1-methyl ester are also disclosed.

Description

This application claims the benefit of U.S. Provisional Patent Application No. 60/126,363, filed Mar. 26, 1999.
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to the formation of particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester (neotame) by, for example, extrusion and/or spheronization with and without binders. Neotame is converted from a light powder to dustless, free-flowing particles suitable for use in a variety of applications. This invention also relates to food products sweetened with the neotame particles, as well as to methods of preparing such food products.
2. Related Background Art
It is known that N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-phenylalanine 1-methyl ester (neotame) is an extremely potent sweetening agent (about 8000X sweeter than sugar) that has the formula
Figure US06365216-20020402-C00001
Clearly, the use of a high potency sweetener such as N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester requires consideration of the ability to deliver the sweetener in a given application. Thus, effective means for delivering neotame in desired compositions are very useful.
Extrusion is a well known technique used in a number of industries for a variety of purposes. For example, food compositions are routinely extruded in order to obtain desired shapes and forms; similarly, other materials such as agricultural compositions and plastics are extruded. In addition, extrusion apparatuses can be used as delivery means for a wide range of products.
Spheronization is a well known technique used in the pharmaceutical industry to provide rounded particles that can be uniformly coated. For example, WO 95/22319 discloses a process for preparing fine particle pharmaceutical formulations by combining dry components with an extrusion aid (typically a pharmaceutically acceptable oil or wax), wetting the mixture, extruding and then spheronizing. This procedure results in fine particle formulations which exhibit improved uniformity of particle size and performance characteristics such as drug release.
WO 93/07859 generally discloses a method of preparation for pharmaceutical pellets comprising melt spheronization, i.e., extrusion under temperatures appropriate to melt the active pharmaceutical agent and necessary excipients and subsequent spheronization.
Spheronization has also been employed in the sweetener industry. WO 89/00819 discloses self-stabilized compositions of dipeptide sweeteners and their salts and complexes, which exhibit heat stability and a sustained release mechanism that insures uniform dissolution and dispersion within baked products. The compositions are produced by spheronizing a dipeptide sweetener, aspartame in particular, with or without a suitable binding agent to produce dense, non-porous spherical granules of narrow particle size distribution. The compositions may be coated with a hydrophobic coating.
Particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester formed by either extrusion or spheronization are not disclosed or suggested by the aforementioned art.
SUMMARY OF THE INVENTION
The present invention is directed to a process for forming particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester. This process comprises the steps of (a) mixing N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester and a plasticizer to form a wet mass; (b) extruding said wet mass to form extrudates; and (c) drying said extrudates to form said particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester. In a preferred embodiment of the present invention, water is used as the plasticizer.
In certain preferred embodiments of the present invention, a binder is incorporated in the wet mass prior to the extruding step. In other preferred embodiments, the wet mass is heated prior to the extruding step.
In further preferred embodiments of the present invention, spheres are formed from the extrudates prior to drying.
This invention is further directed to extruded or spheronized particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester made according to the processes of the present invention.
Additional embodiments of the present invention are directed to food products sweetened with such particles of neotame and to methods of sweetening food products with the particles of neotame of this invention such as extruded neotame, spheronized neotame or the like.
DETAILED DESCRIPTION
N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester (neotame) is a high potency dipeptide sweetener (about 8000X sweeter than sucrose) that has the formula
Figure US06365216-20020402-C00002
The chemical synthesis of neotame is disclosed in U.S. Pat. No. 5,480,668, U.S. Pat. No. 5,510,508 and U.S. Pat. No. 5,728,862, the disclosure of each of which is incorporated by reference herein. Thus, the starting material may be readily prepared by one of ordinary skill without undue experimentation.
Generally, N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester exists as a light, somewhat dusty powder. Extrusion and optional spheronization can be used as particle formation techniques to form relatively dustless, free flowing particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester. Such particles can be regarded as “extrudates” or “spheres”, depending upon their processing and characteristics.
As used herein, the term “particles” includes, for example, “granules” such as “extrudates”, “spheres” and the like, which have been, for example, “granulated”, (e.g., “extruded”, “spheronized” or the like). Also as used herein, the terms “extrudates” or “extruded neotame” refer to preferably cylindrical, free-flowing, relatively non-dusty, mechanically strong granules of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester. Further, as used herein, the terms “spheres” or “spheronized neotame” refer to relatively spherical, smooth, free-flowing, relatively non-dusty, mechanically strong granules. While spheres typically have a smoother surface and may be stronger/harder than extrudates, extrudates offer a cost advantage in that less processing is required. The spheres and extrudates of this invention may be further processed, if desired, to form various other particles, such as, for example, by grinding or chopping.
Any form of neotame may be used in the extrudates and spheres of this invention. For example, salts and metal complexes of neotame may be used, such as disclosed in U.S. Pat. No. 6,291,004, U.S. Pat. No. 6,180,156, U.S. Pat. No. 6,129,942, and U.S. Pat. No. 6,146,680, all filed Sep. 4, 1998, and all of which are incorporated by reference herein. The anhydrous form of neotame is suitable for use in this invention, as well as the various crystalline forms of neotame. Other exemplary forms of neotame that may be useful in this invention include cyclodextrin/neotame complexes such as disclosed in U.S. Provisional Patent Application No. 60/100,867 and co-crystallized neotame disclosed in U.S. Pat. No. 6,214,402, both filed Sep. 17, 1998, and the disclosure of both of which are incorporated by reference herein.
One embodiment of the present invention is directed to a process by which particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester are formed with the use of a binder.
In the first step of this process, N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester, a plasticizer and a binder are mixed to form a wet mass.
Suitable plasticizers include, without limitation, water, glycerol and mixtures thereof. Water is a particularly preferred plasticizer.
Suitable binders include, without limitation, polyvinylpyrollidone (PVP), maltodextrins, microcrystalline cellulose, starches, hydroxypropylmethyl cellulose (HPMC), methylcellulose, hydroxypropyl cellulose (HPC), gum arabic, gelatin, xanthan gum and mixtures thereof. The binder is generally present in the wet mass in an amount of about 0.01-45% by weight, and preferably from 0.5-10% by weight.
Binder can optionally be dissolved in the plasticizer to form a binder solution. The binder solution can then be added to the neotame and other dry ingredients if present. In this way, the binder will be better distributed throughout the wet mass. If this is done using an extruder that has mixing capability (e.g., Extrud-O-Mix by Hosokawa Bepex), then the binder solution could be continuously added and mixed into the dry ingredients. This would help to eliminate the mixing/kneading step and also the need for mixing/kneading equipment.
N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester is generally present in the wet mass in an amount of about 0.5-90% by weight, and preferably from about 1-80% by weight.
The plasticizer is generally present in the wet mass in an amount of 4-45% by weight, and preferably from 15-35% by weight.
Optionally included in the wet mass are carriers and additives. Any typical food ingredient may be incorporated in the wet mass as a carrier or as an additive; one of ordinary skill in this art would readily appreciate the scope of appropriate food ingredients, as well as the acceptable amount of a given food ingredient to incorporate in the wet mass. In preferred embodiments of the present invention, lactose, maltodextrins, dextrose, citric acid, microcrystalline cellulose, sugar, sugar alcohols and mixtures thereof are included in the wet mass as a carrier. In additional preferred embodiments, CaCl2, MgCl2, flavor enhancers/modifiers, acidulants and mixtures thereof are included in the wet mass as additives. Appropriate amounts, as readily determined by one of ordinary skill in the art, of such carriers and additives can be included in the wet mass in order to achieve a desired effect on taste or functionality.
In the second step of the process of the present invention, the wet mass is extruded to form extrudates. Extrusion can be accomplished by any known means, including a low pressure extruder fitted with a die. One skilled in the art can readily choose an appropriate die size in order to obtain the desired final particle size. The wet extrudates can be further cut into uniform length pellets using a cutting device attached to the discharge end of the extruder.
The extrudates are preferably cylindrical in shape and usually take the form of noodles or pellets. The shape and size of the extrudates may vary depending upon the shape and size of the die openings and the use of a cutting device.
In the final step of this embodiment of the present invention, the extrudates are dried. Drying is generally accomplished using a fluidized bed dryer, though any suitable drying method may be employed.
In a preferred embodiment of this process, the extrudates are formed into spheres prior to drying, typically by charging into a marumerizer. As described in Size Enlargement by Agglomeration by Wolfgang Pietsch, pp. 383-385, John Wiley & Sons (1991), a marumerizer consists of a vertical hollow cylinder (bowl) with a horizontal rotating disc (friction plate) therein. The noodle-like extrudates are charged onto the friction plate and almost immediately break into short segments of uniform length. The rotating disc surface can have a variety of textures suited for specific purposes. Typically a grid is applied, the pattern of which corresponds to the desired particle size. The plastic extrudate segments are formed into spheres by contact with the rotating disc as well as by collisions with the wall and between particles. During deformation into spheres and densification, excess moisture may move to the surface or thixotropic behavior may be exhibited by the mass. When this happens, slight dusting with a suitable powder dispenser reduces the probability that particles will stick together.
A second embodiment of the present invention is directed to a process by which particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester are formed without the use of a binder. Without being bound to theory, this is possible because N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester, unlike other known high potency sweeteners, exhibits unique binding properties at the temperatures of the present process. This may be due, in part, to neotame's low melting point (82° C.). The formation of particles without having to use a binder is desirable as it lowers costs and increases product quality. In this way, it is possible to make particles which do not contain any additives. Further, because it is also possible to make compositions having very high neotame concentrations, flexibility in delivering neotame for targeted uses is provided.
In the first step of this embodiment of the present invention, N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester and a plasticizer are mixed to form a wet mass. This can be done in a kneader/continuous mixer.
Suitable plasticizers include, without limitation, water, glycerol and mixtures thereof. Water is a particularly preferred plasticizer.
N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester is generally present in the wet mass in an amount of 65-85% by weight.
The plasticizer is generally present in the wet mass in an amount of 15-35% by weight.
In the second step, the wet mass is heated to promote the binding of the wet mass. Generally, the wet mass is heated to approximately 30° C. to 65° C., and preferably from 40° C. to 60° C. Such heating may be performed in an oven or in a kneader with heated jacket.
Alternatively, both the above-mentioned steps, i.e., mixing and heating, can be accomplished in an extruder that has mixing capabilities and can provide heating either by high shear or by the use of a heating jacket.
Then, as described above in connection with the first embodiment of the present invention, the wet mass is extruded to form extrudates, and the extrudates or spheres are dried. In a preferred embodiment of this process, spheres are formed from the extrudates prior to drying, typically by charging them into a marumerizer.
Alternatively, the wet mass of the present inventive processes can take the form of neotame wetcake, an intermediate stage in the production of neotame. In this way, it is possible to convert neotame wetcake directly into particles which are non-dusty, free-flowing, value-added forms rather than drying the wetcake into neotame powder and then re-wetting the powder to form the wet mass of the present inventive processes. This processing approach will eliminate one drying step and will reduce the processing cost for the manufacture of neotame particles.
The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester particles (extrudates or spheres) of this invention typically have a particle size ranging from about 10 to about 140 mesh. Preferably, the particles have a particle size ranging from about 20 to about 80 mesh.
In the neotame particles of the present invention which contain a binder, the amount of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester is generally from about 25% to about 99.9% and preferably from about 80% to about 99% and most preferably from about 84% to about 96.7% by weight of the particles. In these same particles, the amount of plasticizer is generally from about 0% to about 15% and preferably from about 3% to about 6% by weight of the particles. The amount of binder present in the final neotame particles is generally from about 0.1% to about 60% and preferably from about 0.1% to about 10% by weight of the particles.
In the neotame particles of the present invention which do not contain a binder, the amount of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester is generally from about 85% to about 100% and preferably from about 94% to about 97% by weight of the particles. In these same particles, the amount of plasticizer is generally from about 0% to about 15% and preferably from about 3% to about 6% by weight of the particles.
The neotame particles of this invention may be coated/encapsulated to increase heat stability, etc. Suitable encapsulants include, without limitation, carbohydrates (e.g., starches, gums, maltodextrins, cyclodextrins), proteins (e.g., zein), fats and waxes, sugars, polymers (e.g., polyvinylacetate, polyethylene), hydroxypropylmethyl cellulose and mixtures thereof.
The extruded or spheronized N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester of this invention is suitable for use in any food to supplement or replace natural sweeteners, as well as other high intensity sweeteners, normally used as sweeteners. The term food as used herein includes, for example, beverages, fluid dairy products, non-dairy products, condiments, baked goods, frostings, bakery fillings, candy and chewing gum. The extruded or spheronized N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester may also be used in table top sweeteners. In that regard, the disclosures of U.S. Application Ser. Nos. 09/213,263, 09/213,860, 09/215,460, and 09/215,461, directed to the use of neotame in dairy products, baked goods, beverages and table-top applications, respectively, are incorporated by reference herein.
Beverages include, without limitation, carbonated soft drinks, including cola, lemon-lime, root beer, heavy citrus, fruit flavored and cream sodas; powdered soft drinks, as well as liquid concentrates such as fountain syrups and cordials; coffee and coffee-based drinks, coffee substitutes and cereal-based beverages; teas, including dry mix products as well as ready-to-drink teas (herbal and tea-leaf based); fruit and vegetable juices and juice flavored beverages as well as juice drinks, nectars, concentrates, punches and “ades”; sweetened and flavored waters, both carbonated and still; sport/energy/health drinks; alcoholic beverages plus alcohol-free and other low-alcohol products including beer and malt beverages, cider, and wines (still, sparkling, fortified wines and wine coolers); other beverages processed with heating (infusions, pasteurization, ultra high temperature, ohmic heating or commercial aseptic sterilization) and hot-filled packaging; and cold-filled products made through filtration or other preservation techniques.
Fluid dairy products include, without limitation, non-frozen, partially frozen and frozen fluid dairy products such as, for example, milks, ice creams, cultured dairy products such as yogurts and the like. Non-dairy products include, for example, sorbets.
Condiments include, without limitation, ketchup, mayonnaise, salad dressing, Worcestershire sauce, fruit-flavored sauce, chocolate sauce, tomato sauce, chili sauce, and mustard.
Baked goods include, without limitation, cakes, cookies, pastries, breads, donuts and the like.
Bakery fillings include, without limitation, low or neutral pH fillings, high, medium or low solids fillings, fruit or milk based (pudding type or mousse type) fillings, hot or cold make-up fillings and non-fat to full-fat fillings.
This invention is also directed to a sweetened food composition, such as described above, containing an effective amount of the N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester particles of this invention (e.g., extruded or spheronized neotame) to sweeten the food composition. Determination of the amount of neotame particles to be added to the food composition can be readily determined by one of ordinary skill in the art.
The particles of neotame (e.g., extruded or spheronized neotame) of the present invention can be used for this purpose alone or in combination with known bulking agents. Suitable bulking agents include, but are not limited to, dextrose, maltodextrin, lactose, inulin, polyols, polydextrose, cellulose and cellulose derivatives and organic acids including, but not limited to, citric acid and malic acid. Such a product may be suitable for use especially for table-top sweeteners and powdered soft drinks. A table-top sweetener comprising the present particles of neotame (e.g., extruded or spheronized neotame) may also include any other ingredients commonly present in table-top sweeteners in order to tailor the taste of the product to a specific end use. A table-top sweetener comprising the present particles of neotame may take any known form. Suitable forms include, but are not limited to, sachets including the sweetener in powder or granular form, tablets, liquid sweeteners, and jar, pouches, pocket or other forms in which the sweetener may be measured in, for example, spoon for spoon form.
The particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester (e.g., extruded or spheronized neotame) of this invention may be used in combination with known natural sweeteners as well as other high intensity sweeteners. Sweeteners that may be employed include, without limitation, aspartame, acesulfame salts (e.g., acesulfame-K), sucralose, saccharin, alitame, cyclamates, stevia derivatives, thaumatin, sucrose (liquid and granulated), high fructose corn syrup, high conversion corn syrup, crystalline fructose, glucose (dextrose), polyol sugar alcohols, invert sugar and mixtures thereof.
Alternatively, any of these known natural sweeteners or other high intensity sweeteners may be combined with neotame, the plasticizer and the optional binder in the present inventive processes to form the wet mass.
The Examples which follow are intended as an illustration of certain preferred embodiments of the invention, and no limitation of the invention is implied.
EXAMPLE 1 Spheronization of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl Ester without Binder
N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester (75 wt %) and water (25 wt %) were manually mixed and kneaded. This dough was pre-heated in an oven and extruded at 40° C. using 0.8 mm die. Very good, smooth extrudates were obtained at a high rate. These extrudates were processed in a marumerizer for 30 seconds to form spheres. The spheres were dried in a fluid bed dryer at 50° C. Spherical particles were obtained without any clumps, fines or dust. The spheres did not disintegrate even after shipping. The moisture content of the particles was 5.2% as measured using Karl Fischer titration. The dissolution rate of the particles was: 670 ppm totally dissolved in 20° C. water in 5 minutes. The neotame assay conducted on the particles showed that it survived the process with minimal formation of degradants.
EXAMPLE 2 Spheronization of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl Ester with Binder
N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester (80 wt %), water (15 wt %) and polyvinylpyrollidone (5 wt %) were manually mixed and kneaded. The mixture was extruded using a low pressure extruder with a 0.8 mm die (model DG-L1, LCI). The extrudates were spheronized in a marumerizer (model QJ-400, LCI) for 30 seconds, resulting in good spheres with no clumps. These spheres were dried in a fluid bed dryer at 50° C. The spheres did not disintegrate in the dryer. Even after being shipped, the spheres remained intact, indicating their strength. The moisture content of the spherical particles was 5.1%, as measured using Karl Fischer titration. The dissolution rate of the particles was: 670 ppm totally dissolved in 20° C. water in 1.5 minutes. The neotame assay conducted on the particles showed that it survived the process with minimal formation of degradants.
EXAMPLES 3-7
Examples 3-7 were prepared in a manner substantially similar to Example 2, except the components employed differed as shown in Table 1 below.
TABLE 1
wet mass
1 75% neotame
25% water
(heated to 40° C.)
2 80% neotame
15% water
5% PVP
3 71.4% neotame
14.3% water
9.5% M100
4.8% avicel
4 33.9% neotame
33.9% avicel
8.8% PVP
23.5% water
5 12.3% neotame
18.1% CaCl2
41.1% MgCl2
4.8% PVP
19.7% avicel
4% water
6 42.5% neotame
42.5% lactose
5.2% PVP
9.8% water
7 22.1% neotame
66.2% lactose
5.5% PVP
6.2% water
The samples were analyzed for N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester and N-[N-3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine (demethoxylated neotame), a primary degradant, content by high performance liquid chromatography (HPLC). The samples were also tested for hardness, dissolution rate and Karl Fischer moisture. The results are shown in Table 2.
In particular, hardness was tested in the following manner. Approximately 75 g particulate material was screened on an 80 mesh screen. The material was shaken using a Ro-Tap® Testing Sieve Shaker (model B, C. E. Tyler Combustion Engineering Inc.) for ten minutes with a hammer. About 50±1 g of material retained on the screen was transferred to the pan of the screen assembly. Ten 0.5″ steel balls were placed in the pan, and clean 80 mesh screen was positioned above the pan. The Ro-Tap® shaker was run for another ten minutes without the hammer. The assembly was removed from the shaker, and the steel balls were removed from the pan. The material was transferred from the pan to the 80 mesh screen. The screen and pan were reassembled and placed in the Ro-Tap®. The shaker was run for another ten minutes with the hammer. The screen assembly was removed, and the material retained on the 80 mesh screen was weighed to the nearest 0.1 g. Hardness was calculated as follows: % hardness=(weight retained on 80 mesh/total weight of sample charged)×100.
The dissolution rate of each sample was measured as a function of absorbance at 258 nm using a spectrophotometer. Sample (0.1 g) was added to 150 g deionized water at 20° C. The water was stirred, and absorbance was measured versus time until it reached its highest value and became constant. The time required to reach the highest level of absorbance has been reported as “dissolution rate”.
TABLE 2
Characteristics of Spheronized N-[N-(3,3-
dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl
ester.
neotame
in degradant*
finished in Karl
sample finished Fischer
(wt/ sample mois- dissolution hardness
wt %) (wt/wt %) ture** rate (%) comments
1 91.5 0.075 5.2   5 min 53.4 spheres
2 89.3 0.074 5.6 1.5 min 93.2 spheres
3 84.4 0.083 6.1 insoluble 86.5 spheres
due to
avicel
content
4 43.8 0.051 4.1* insoluble 86.7 spheres/
due to rods/
avicel fines
content
5 14.4 0.019 8.9* insoluble 95.7 cylindrical
due to particles
avicel with
content rounded
edges
6 40.6 0.045 6.1 2.3 min 93.2 spheres,
some
cylindrical
particles
with
rounded
edges
7 23.8 0.032 5.7 1.0 min 97.2 cylindrical
particles
with
rounded
edges
*demethoxylated neotame
**These moisture values were obtained using a Computrac Moisture Analyzer (Arizona Instruments Corp.) with a 100° C. oven temperature, as opposed to using the Karl Fischer method.
EXAMPLE 8 Extrusion of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl Ester with Binder
N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester (80 wt %), water (15 wt %) and polyvinylpyrollidone (5 wt %) were manually mixed and kneaded. The mixture was extruded using a low pressure extruder with a 0.8 mm die (model DG-L1, LCI). The extrudates were dried in a fluid bed dryer at 50° C. The Karl Fischer moisture content, dissolution rate and hardness for these cylindrical particles with rounded edges were determined via the same methods outlined in Examples 3-7 above. Specifically, the moisture content was 5.3%, the dissolution rate was 1.5 min and the hardness was 75.3%.
EXAMPLE 9 Extruding Neotame Wetcake
Neotame wetcake containing 31.2% moisture was fed to an extruder (Extrud-O-Mix, model EM-2, single screw, axial, low pressure, Hosokawa Bepex) through the screw feeder. Wet extrudates were smooth but long and warm; some of the extrudates stuck together. They were screened manually using an 8 mesh screen to break up the larger agglomerates and then dried in a fluid bed dryer with inlet air temperature at 62° C. It was dried until the outlet air temperature rose to 52° C. No breakage of particles was observed during drying. The dried extrudates contained 2.1% moisture (tested using Karl Fischer titration). Dissolution rate was determined to be 15 minutes using the UV absorbance method described in connection with Examples 3-7. Hardness was 92.9%, as measured in the same manner as in Examples 3-7.
EXAMPLES 10-12 Extrudates Containing Neotame and Other Sweeteners
Sweetener blends were formed using extrusion. Extrudates were prepared in a manner substantially similar to Example 8, except the components employed differed as shown in Table 3. All extrudates were formed using the same extruder (Extrud-O-Mix, EM-2, Hosokawa Bepex). All extrudates were dried using STREA-1 (Aeromatic).
TABLE 3
wet mass
composition extrusion drying dissolution
10 2.1% neotame smooth, very long inlet air: 62° C. 14 minutes
66.4% sticky extrudates outlet air max:
aspartame 52° C., minimal
2.7% HPMC* dust
28.8% water
11 2.0% neotame extrudates inlet air: 70° C.  3 minutes
64.7% recycled through outlet air max:
aspartame extruder; 57° C., minimal
33.3% water collected dust
extrudates formed
at 49-52° C.;
long sticky
extrudates when
warm; on cooling,
quickly case-
harden and
become non-
sticky
12 2.7% neotame long, slightly inlet air: 50° C. 3.5 minutes 
43.7% sticky extrudates; outlet air max:
aspartame extruded at 43° C., minimal
43.7% ace-K** 32° C. dust
9.9% water
*hydroxypropylmethyl cellulose
**acesulfame-K
EXAMPLES 13-16 Extrusion of Neotame with Different Grades of Binder
Four different grades of hydroxypropylmethyl cellulose, namely Methocel K3 Premium, Methocel E3 Premium, Methocel E15 Premium and Methocel K35, all from Dow Chemical Company, were used to form extrudates as set forth in Table 4. The main difference between these grades is their viscosity in water solution. K3 and E3 have the lowest, E15 has intermediate and K35 has the highest viscosity. An EXD-60 extruder (LCI) was used for extrusion. STREA-1 fluid bed dryer (Aeromatic) was used for drying the wet extrudates.
TABLE 4
hard-
wet mass extrusion drying dissolution ness
13 72.2% neotame very long, inlet air: 50° C. 4.0 minutes 94.9%
3.6% HPMC* sticky outlet air max:
E3 extrudates; 42° C.
24.2% water 1 mm
diameter
14 74.6% neotame long, less inlet air: 50° C. 2.5 minutes 94.0%
3.7% HPMC sticky outlet air max:
K3 extrudates; 42° C.
21.7% water 1 mm
diameter
15 73.5% neotame too long inlet air: 50° C. 7.0 minutes 97.2%
3.7% HPMC and sticky outlet air max:
E15 LV extrudates; 42° C.
22.8% water 1 mm
diameter
16 74.0% neotame too long inlet air: 50° C. 8.5 minutes 99.6%
3.7% HPMC and sticky outlet air max:
K35 extrudates 42° C.
22.3% water
*hydroxypropylmethyl cellulose
Other variations and modifications of this invention will be obvious to those skilled in this art. This invention is not to be limited except as set forth in the following claims.

Claims (90)

What is claimed is:
1. A process for forming particles of N-[(N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester comprising the steps of:
(a) forming a wet mass by mixing N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester and a plasticizer;
(b) extruding said wet mass to form extrudates; and
(c) drying said extrudates to form said particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester.
2. The process according to claim 1, wherein said plasticizer is water.
3. The process according to claim 1, wherein a binder is added to said wet mass prior to said extruding step.
4. The process according to claim 3, wherein said binder is selected from the group consisting of polyvinylpyrollidone, maltodextrins, microcrystalline cellulose, starches, hydroxypropylmethyl cellulose, methylcellulose, hydroxypropyl cellulose, gum arabic, gelatin, xanthan gum and mixtures thereof.
5. The process according to claim 1, wherein said wet mass is heated to promote the binding of said wet mass prior to said extruding step.
6. The process according to claim 5, wherein said wet mass is heated to a temperature from about 30° C. to about 65° C.
7. The process according to claim 1 further comprising the step of forming spheres from said extrudates prior to said drying step.
8. The process according to claim 7, wherein said spheres are formed with a marumerizer.
9. The process according to claim 7, wherein a binder is added to said wet mass prior to said extruding step.
10. The process according to claim 9, wherein said binder is selected from the group consisting of polyvinylpyrollidone, maltodextrins, microcrystalline cellulose, starches, hydroxypropylmethyl cellulose, methylcellulose, hydroxypropyl cellulose, gum arabic, gelatin, xanthan gum and mixtures thereof.
11. The process according to claim 7, wherein said wet mass is heated to promote the binding of said wet mass prior to said extruding step.
12. The process according to claim 11, wherein said wet mass is heated to a temperature from about 30° C. to about 65° C.
13. The process according to claim 1, wherein the wet mass further comprises a carrier.
14. The process according to claim 13, wherein the carrier is selected from the group consisting of lactose, maltodextrins, dextrose, citric acid, microcrystalline cellulose, sugar, sugar alcohols and mixtures thereof.
15. The process according to claim 1, wherein the wet mass further comprises an additive.
16. The process according to claim 15, wherein the additive is selected from the group consisting of CaCl2, MgCl2, flavor enhancers/modifiers, acidulants and mixtures thereof.
17. The process according to claim 1, wherein the wet mass further comprises a known natural sweetener or other high intensity sweetener.
18. The process according to claim 17, wherein said known natural sweetener or other high intensity sweetener is selected from the group consisting of aspartame, acesulfame salts, sucralose, saccharin, alitame, cyclamates, stevia derivatives, thaumatin, sucrose, high fructose corn syrup, high conversion corn syrup, crystalline fructose, glucose, dextrose, polyol sugar alcohols, invert sugar and mixtures thereof.
19. A N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition made according to the process comprising the steps of:
(a) forming a wet mass by mixing N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester and a plasticizer;
(b) extruding said wet mass to form extrudates; and
(c) drying said extrudates to form particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester.
20. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 19, wherein said plasticizer is water.
21. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 19, wherein a binder is added to said wet mass prior to said extruding step.
22. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 21, wherein said binder is selected from the group consisting of polyvinylpyrollidone, maltodextrins, microcrystalline cellulose, starches, hydroxypropylmethyl cellulose, methylcellulose, hydroxypropyl cellulose, gum arabic, gelatin, xanthan gum and mixtures thereof.
23. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 19, wherein said wet mass is heated to promote the binding of said wet mass prior to said extruding step.
24. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 23, wherein said wet mass is heated to a temperature from about 30° C. to about 65° C.
25. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 21, wherein said binder is present in said particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester in an amount from about 0.1% to about 60% by weight.
26. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 21, wherein said N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester is present in said particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester in an amount from about 25% to about 99.9% by weight.
27. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 21, wherein said plasticizer is present in said particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester in an amount from about 0% to about 15% by weight.
28. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 23, wherein said N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester is present in said particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester in an amount from about 85% to about 100% by weight.
29. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 23, wherein said plasticizer is present in said particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester in an amount from about 0% to about 15% by weight.
30. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 19 further comprising the step of forming spheres from said extrudates prior to said drying step.
31. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 30, wherein said spheres are formed with a marumerizer.
32. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 30, wherein a binder is added to said wet mass prior to said extruding step.
33. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 32, wherein said binder is selected from the group consisting of polyvinylpyrollidone, maltodextrins, microcrystalline cellulose, starches, hydroxypropylmethyl cellulose, methylcellulose, hydroxypropyl cellulose, gum arabic, gelatin, xanthan gum and mixtures thereof.
34. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 30, wherein said wet mass is heated to promote the binding of said wet mass prior to said extruding step.
35. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 34, wherein said wet mass is heated to a temperature from about 30° C. to about 65° C.
36. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 32, wherein said binder is present in said particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester in an amount from about 0.1% to about 60% by weight.
37. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 32, wherein said N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester is present in said particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester in an amount from about 25% to about 99.9% by weight.
38. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 32, wherein said plasticizer is present in said particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester in an amount from about 0% to about 15% by weight.
39. The N-[N-(3,3-dimethylbutyl )-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 34, wherein said N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester is present in said particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester in an amount from about 85% to about 100% by weight.
40. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 34, wherein said plasticizer is present in said particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester in an amount from about 0% to about 15% by weight.
41. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 19, wherein the wet mass further comprises a carrier.
42. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 41, wherein the carrier is selected from the group consisting of lactose, maltodextrins, dextrose, citric acid, microcrystalline cellulose, sugar, sugar alcohols and mixtures thereof.
43. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 19, wherein the wet mass further comprises an additive.
44. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 43, wherein the additive is selected from the group consisting of CaCl2, MgCl2, flavor enhancers/modifiers, acidulants and mixtures thereof.
45. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 19, wherein the wet mass further comprises a known natural sweetener or other high intensity sweetener.
46. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 45, wherein said known natural sweetener or other high intensity sweetener is selected from the group consisting of aspartame, acesulfame salts, sucralose, saccharin, alitame, cyclamates, stevia derivatives, thaumatin, sucrose, high fructose corn syrup, high conversion corn syrup, crystalline fructose, glucose, dextrose, polyol sugar alcohols, invert sugar and mixtures thereof.
47. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 19, wherein said particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition have a particle size from about 10 to about 140 mesh.
48. A method of sweetening a food by including in said food a N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 19 in an amount effective to sweeten said food.
49. The method according to claim 48, wherein said food is selected from the group consisting of beverages, fluid dairy products, condiments, baked goods, frostings, bakery fillings, candy and chewing gum.
50. A method of preparing a table-top sweetener by including in said table-top sweetener a N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 19 in an amount effective to sweeten said table-top sweetener.
51. A sweetened food comprising a N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 19 in an amount effective to sweeten the food.
52. The sweetened food according to claim 51, wherein said food is selected from the group consisting of beverages, fluid dairy products, condiments, baked goods, frostings, bakery fillings, candy and chewing gum.
53. A table-top sweetener comprising a N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 19 in an amount effective to sweeten said table-top sweetener.
54. A method of sweetening a food by including in said food a N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 30 in an amount effective to sweeten said food.
55. The method according to claim 54, wherein said food is selected from the group consisting of beverages, fluid dairy products, condiments, baked goods, frostings, bakery fillings, candy and chewing gum.
56. A method of preparing a table-top sweetener by including in said table-top sweetener a N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 30 in an amount effective to sweeten said table-top sweetener.
57. A sweetened food comprising a N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 30 in an amount effective to sweeten the food.
58. The sweetened food according to claim 57, wherein said food is selected from the group consisting of beverages, fluid dairy products, condiments, baked goods, frostings, bakery fillings, candy and chewing gum.
59. A table-top sweetener comprising a N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 30 in an amount effective to sweeten said table-top sweetener.
60. A process for forming particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester comprising the steps of:
(a) extruding neotame wetcake to form extrudates; and
(b) drying said extrudates to form said particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester.
61. The process according to claim 60, wherein said wetcake is heated to promote the binding of said wetcake prior to said extruding step.
62. The process according to claim 61, wherein said wetcake is heated to a temperature from about 30° C. to about 65° C.
63. The process according to claim 60 further comprising the step of forming spheres from said extrudates prior to said drying step.
64. The process according to claim 63, wherein said spheres are formed with a marumerizer.
65. The process according to claim 63, wherein said wetcake is heated to promote the binding of said wetcake prior to said extruding step.
66. The process according to claim 65, wherein said wet mass is heated to a temperature from about 30° C. to about 65° C.
67. A N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition made according to the process comprising the steps of:
(a) extruding neotame wetcake to form extrudates; and
(b) drying said extrudates to form particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester.
68. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 67, wherein said wetcake is heated to promote the binding of said wetcake prior to said extruding step.
69. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 68, wherein said wetcake is heated to a temperature from about 30° C. to about 65° C.
70. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 67, wherein said N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester is present in said particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester in an amount from about 85% to about 100% by weight.
71. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 67, wherein water is present in said particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester in an amount from about 0% to about 15% by weight.
72. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 67 further comprising the step of forming spheres from said extrudates prior to said drying step.
73. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 72, wherein said spheres are formed with a marumerizer.
74. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 72, wherein said wetcake is heated to promote the binding of said wetcake prior to said extruding step.
75. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 74, wherein said wetcake is heated to a temperature from about 30° C. to about 65° C.
76. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 72, wherein said N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester is present in said particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester in an amount from about 85% to about 100% by weight.
77. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 72, wherein water is present in said particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester in an amount from about 0% to about 15% by weight.
78. The N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 67, wherein said particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition have a particle size from about 10 to about 140 mesh.
79. A method of sweetening a food by including in said food a N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 67 in an amount effective to sweeten said food.
80. The method according to claim 79, wherein said food is selected from the group consisting of beverages, fluid dairy products, condiments, baked goods, frostings, bakery fillings, candy and chewing gum.
81. A method of preparing a table-top sweetener by including in said table-top sweetener a N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 67 in an amount effective to sweeten said table-top sweetener.
82. A sweetened food comprising a N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 67 in an amount effective to sweeten the food.
83. The sweetened food according to claim 82, wherein said food is selected from the group consisting of beverages, fluid dairy products, condiments, baked goods, frostings, bakery fillings, candy and chewing gum.
84. A table-top sweetener comprising a N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 67 in an amount effective to sweeten said table-top sweetener.
85. A method of sweetening a food by including in said food a N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 72 in an amount effective to sweeten said food.
86. The method according to claim 85, wherein said food is selected from the group consisting of beverages, fluid dairy products, condiments, baked goods, frostings, bakery fillings, candy and chewing gum.
87. A method of preparing a table-top sweetener by including in said table-top sweetener a N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 72 in an amount effective to sweeten said table-top sweetener.
88. A sweetened food comprising a N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 72 in an amount effective to sweeten the food.
89. The sweetened food according to claim 88, wherein said food is selected from the group consisting of beverages, fluid dairy products, condiments, baked goods, frostings, bakery fillings, candy and chewing gum.
90. A table-top sweetener comprising a N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester composition according to claim 72 in an amount effective to sweeten said table-top sweetener.
US09/534,067 1999-03-26 2000-03-24 Particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester Expired - Lifetime US6365216B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US09/534,067 US6365216B1 (en) 1999-03-26 2000-03-24 Particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12636399P 1999-03-26 1999-03-26
US09/534,067 US6365216B1 (en) 1999-03-26 2000-03-24 Particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester

Publications (1)

Publication Number Publication Date
US6365216B1 true US6365216B1 (en) 2002-04-02

Family

ID=22424420

Family Applications (1)

Application Number Title Priority Date Filing Date
US09/534,067 Expired - Lifetime US6365216B1 (en) 1999-03-26 2000-03-24 Particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester

Country Status (4)

Country Link
US (1) US6365216B1 (en)
EP (1) EP1164872A1 (en)
AU (1) AU4028300A (en)
WO (1) WO2000057725A1 (en)

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020090436A1 (en) * 2000-07-18 2002-07-11 Schroeder Stephen A. Method of preparing liquid compositions for delivery of N- [N- (3,3-dimethylbutyl-L-alpha-aspartyl] -L-phenylalanine 1 -methyl ester in food and beverage systems
US6692778B2 (en) 1998-06-05 2004-02-17 Wm. Wrigley Jr. Company Method of controlling release of N-substituted derivatives of aspartame in chewing gum
US20050191396A1 (en) * 2004-03-01 2005-09-01 Randy Seltzer Flavored artificial sweetener
US20070116822A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-potency sweetener composition with saponin and compositions sweetened therewith
US20070116831A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company Dental Composition with High-Potency Sweetener
US20070116828A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company Natural High-Potency Tabletop Sweetener Compositions with Improved Temporal and/or Flavor Profile, Methods for Their Formulation, and Uses
US20070116836A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-Potency Sweetener Composition for Treatment and/or Prevention of Osteoporosis and Compositions Sweetened Therewith
US20070116832A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-Potency Sweetener Composition with Mineral and Compositions Sweetened Therewith
US20070116827A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-Potency Sweetener Composition with Glucosamine and Compositions Sweetened Therewith
US20070116825A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company Confection with High-Potency Sweetener
US20070134391A1 (en) * 2005-11-23 2007-06-14 The Coca-Cola Company High-Potency Sweetener Composition for Treatment and/or Prevention of Autoimmune Disorders and Compositions Sweetened Therewith
US20070275147A1 (en) * 2005-11-23 2007-11-29 The Coca-Cola Company Synthetic sweetener compositions with improved temporal profile and/or flavor profile, methods for their formulation, and uses
US20080107787A1 (en) * 2006-11-02 2008-05-08 The Coca-Cola Company Anti-Diabetic Composition with High-Potency Sweetener
US20080108710A1 (en) * 2005-11-23 2008-05-08 The Coca-Cola Company High-Potency Sweetener Composition With Preservative and Compositions Sweetened Therewith
US20080107776A1 (en) * 2006-11-02 2008-05-08 The Coca-Cola Company High-Potency Sweetener Composition With Phytoestrogen and Compositions Sweetened Therewith
US20080292775A1 (en) * 2007-05-22 2008-11-27 The Coca-Cola Company Delivery Systems for Natural High-Potency Sweetener Compositions, Methods for Their Formulation, and Uses
US20090159091A1 (en) * 2007-12-19 2009-06-25 Philip Morris Usa Inc. Activated carbon from microcrystalline cellulose
US20090280211A1 (en) * 2006-05-17 2009-11-12 Friedman Robert B Method of preparing a food product
US20110070337A1 (en) * 2009-09-21 2011-03-24 Whitewave Services, Inc. Reduced Calorie Soy Beverage
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
EP3009010A1 (en) 2011-12-19 2016-04-20 PureCircle SDN BHD Methods for purifying steviol glycosides and uses of the same
US10711024B2 (en) 2014-12-17 2020-07-14 Cargill, Incorporated Steviol glycoside compounds, compositions for oral ingestion or use, and method for enhancing steviol glycoside solubility
US11344051B2 (en) 2015-04-03 2022-05-31 Dsm Ip Assets B.V. Steviol glycosides
EP4159050A1 (en) 2015-11-30 2023-04-05 Cargill, Incorporated Steviol glycoside compositions for oral ingestion or use

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6984732B2 (en) 2003-03-31 2006-01-10 Mcneil-Ppc, Inc. High-intensity sweetener composition and delivery of same
WO2011024197A1 (en) * 2009-08-25 2011-03-03 V.B. Medicare Pvt. Ltd. Process for producing a reduced bulk density sucralose containing sweetener system and products thereof

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0229730A2 (en) 1986-01-16 1987-07-22 The Dow Chemical Company Thermally stable particulate artificial sweeteners
WO1989000819A1 (en) 1987-07-29 1989-02-09 The Nutrasweet Company Self stabilized dipeptide sweeteners
WO1993007859A1 (en) 1991-10-23 1993-04-29 Warner-Lambert Company Novel pharmaceutical pellets and process for their production
WO1995022319A1 (en) 1994-02-16 1995-08-24 Abbott Laboratories Process for preparing fine particle pharmaceutical formulations
US5480668A (en) 1992-11-12 1996-01-02 Nofre; Claude N-substituted derivatives of aspartame useful as sweetening agents
US5510508A (en) 1994-05-09 1996-04-23 Claude; Nofre Method of preparing a compound derived from aspartame, useful as a sweetening agent
US5728862A (en) 1997-01-29 1998-03-17 The Nutrasweet Company Method for preparing and purifying an N-alkylated aspartame derivative
WO1999012957A1 (en) 1997-09-11 1999-03-18 The Nutrasweet Company BASIC SALTS OF N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHE NYLALANINE 1-METHYL ESTER
WO1999012955A1 (en) 1997-09-11 1999-03-18 The Nutrasweet Company METAL COMPLEXES OF N-[N-(3,3-DIMETHYLBUTYL) -L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER
WO1999012954A1 (en) 1997-09-11 1999-03-18 The Nutrasweet Company SWEETENER SALTS OF N-[N-(3,3-DIMETHYLBUTYL) -L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER
WO1999012956A1 (en) 1997-09-11 1999-03-18 The Nutrasweet Company ACID SALTS OF N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER
WO1999062354A1 (en) 1998-06-05 1999-12-09 Wm. Wrigley Jr. Company Method of controlling release of n-substituted derivatives of aspartame in chewing gum and gum produced thereby
WO2000015049A1 (en) 1998-09-17 2000-03-23 The Nutrasweet Company THE USE OF CYCLODEXTRIN TO STABILIZE N-[N- (3,3-DIMETHYLBUTYL) -1-α- ASPARTYL] -L-PHENYLALANINE 1-METHYL ESTER
WO2000031118A1 (en) 1998-11-20 2000-06-02 The Nutrasweet Company AMORPHOUS N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57150361A (en) * 1981-03-10 1982-09-17 Ajinomoto Co Inc Granule of dipeptide sweetener
JPS58155054A (en) * 1982-03-10 1983-09-14 Ajinomoto Co Inc Sugar crystal containing dipeptide sweetener and its preparation

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0229730A2 (en) 1986-01-16 1987-07-22 The Dow Chemical Company Thermally stable particulate artificial sweeteners
WO1989000819A1 (en) 1987-07-29 1989-02-09 The Nutrasweet Company Self stabilized dipeptide sweeteners
WO1993007859A1 (en) 1991-10-23 1993-04-29 Warner-Lambert Company Novel pharmaceutical pellets and process for their production
US5480668A (en) 1992-11-12 1996-01-02 Nofre; Claude N-substituted derivatives of aspartame useful as sweetening agents
WO1995022319A1 (en) 1994-02-16 1995-08-24 Abbott Laboratories Process for preparing fine particle pharmaceutical formulations
US5510508A (en) 1994-05-09 1996-04-23 Claude; Nofre Method of preparing a compound derived from aspartame, useful as a sweetening agent
US5728862A (en) 1997-01-29 1998-03-17 The Nutrasweet Company Method for preparing and purifying an N-alkylated aspartame derivative
WO1999012957A1 (en) 1997-09-11 1999-03-18 The Nutrasweet Company BASIC SALTS OF N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHE NYLALANINE 1-METHYL ESTER
WO1999012955A1 (en) 1997-09-11 1999-03-18 The Nutrasweet Company METAL COMPLEXES OF N-[N-(3,3-DIMETHYLBUTYL) -L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER
WO1999012954A1 (en) 1997-09-11 1999-03-18 The Nutrasweet Company SWEETENER SALTS OF N-[N-(3,3-DIMETHYLBUTYL) -L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER
WO1999012956A1 (en) 1997-09-11 1999-03-18 The Nutrasweet Company ACID SALTS OF N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER
WO1999062354A1 (en) 1998-06-05 1999-12-09 Wm. Wrigley Jr. Company Method of controlling release of n-substituted derivatives of aspartame in chewing gum and gum produced thereby
WO2000015049A1 (en) 1998-09-17 2000-03-23 The Nutrasweet Company THE USE OF CYCLODEXTRIN TO STABILIZE N-[N- (3,3-DIMETHYLBUTYL) -1-α- ASPARTYL] -L-PHENYLALANINE 1-METHYL ESTER
WO2000031118A1 (en) 1998-11-20 2000-06-02 The Nutrasweet Company AMORPHOUS N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Patent Abstracts of Japan, vol. 006, No. 257 (C-140), Dec. 16, 1982 (corresponds to JP 57-150361).
Patent Abstracts of Japan, vol. 007, No. 277 (C-199), Dec. 9, 1983 (corresponds to JP 58-155054).
W. Pietsch, "Size Enlargement by Agglomeration", John Wiley & Sons, pp. 383-385 (1991).

Cited By (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6692778B2 (en) 1998-06-05 2004-02-17 Wm. Wrigley Jr. Company Method of controlling release of N-substituted derivatives of aspartame in chewing gum
US20040096544A1 (en) * 1998-06-05 2004-05-20 Wm. Wrigley Jr. Comapny. Method of controlling release of N-substituted derivatives of aspartame in chewing gum and gum produced thereby
US7416751B2 (en) 1998-06-05 2008-08-26 Wm. Wrigley Jr. Company Method of controlling release of N-substituted derivatives of aspartame in chewing gum and gum produced thereby
US20020090436A1 (en) * 2000-07-18 2002-07-11 Schroeder Stephen A. Method of preparing liquid compositions for delivery of N- [N- (3,3-dimethylbutyl-L-alpha-aspartyl] -L-phenylalanine 1 -methyl ester in food and beverage systems
US7326430B2 (en) 2000-07-18 2008-02-05 The Nutrasweet Company Method of preparing liquid compositions for delivery of N-[N- (3,3-dimethylbutyl-L-α-aspartyl]-L-phenylalanine 1-methyl ester in food and beverage systems
US7258885B2 (en) * 2004-03-01 2007-08-21 Tasty-Trim, Inc. Flavored artificial sweetener
US20050191396A1 (en) * 2004-03-01 2005-09-01 Randy Seltzer Flavored artificial sweetener
US20080038433A1 (en) * 2004-03-01 2008-02-14 Tasty-Trim, Inc. Flavored artificial sweetener
US20070116831A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company Dental Composition with High-Potency Sweetener
US20070116828A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company Natural High-Potency Tabletop Sweetener Compositions with Improved Temporal and/or Flavor Profile, Methods for Their Formulation, and Uses
US20070116825A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company Confection with High-Potency Sweetener
US20070134391A1 (en) * 2005-11-23 2007-06-14 The Coca-Cola Company High-Potency Sweetener Composition for Treatment and/or Prevention of Autoimmune Disorders and Compositions Sweetened Therewith
US20070116832A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-Potency Sweetener Composition with Mineral and Compositions Sweetened Therewith
US20070275147A1 (en) * 2005-11-23 2007-11-29 The Coca-Cola Company Synthetic sweetener compositions with improved temporal profile and/or flavor profile, methods for their formulation, and uses
US20070116836A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-Potency Sweetener Composition for Treatment and/or Prevention of Osteoporosis and Compositions Sweetened Therewith
US20070116827A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-Potency Sweetener Composition with Glucosamine and Compositions Sweetened Therewith
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
US20080108710A1 (en) * 2005-11-23 2008-05-08 The Coca-Cola Company High-Potency Sweetener Composition With Preservative and Compositions Sweetened Therewith
US20070116822A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-potency sweetener composition with saponin and compositions sweetened therewith
US20090280211A1 (en) * 2006-05-17 2009-11-12 Friedman Robert B Method of preparing a food product
US20080107776A1 (en) * 2006-11-02 2008-05-08 The Coca-Cola Company High-Potency Sweetener Composition With Phytoestrogen and Compositions Sweetened Therewith
US20080107787A1 (en) * 2006-11-02 2008-05-08 The Coca-Cola Company Anti-Diabetic Composition with High-Potency Sweetener
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
US20080292775A1 (en) * 2007-05-22 2008-11-27 The Coca-Cola Company Delivery Systems for Natural High-Potency Sweetener Compositions, Methods for Their Formulation, and Uses
AU2008256957B2 (en) * 2007-05-22 2014-03-27 The Coca-Cola Company Delivery systems for natural high-potency sweetener compositions, methods for their formulation, and uses
WO2008147723A1 (en) * 2007-05-22 2008-12-04 The Coca-Cola Company Delivery systems for natural high-potency sweetener compositions, methods for their formulation, and uses
US20090159091A1 (en) * 2007-12-19 2009-06-25 Philip Morris Usa Inc. Activated carbon from microcrystalline cellulose
US8555896B2 (en) 2007-12-19 2013-10-15 Philip Morris Usa Inc. Activated carbon from microcrystalline cellulose
US20110070337A1 (en) * 2009-09-21 2011-03-24 Whitewave Services, Inc. Reduced Calorie Soy Beverage
EP4124245A1 (en) 2011-12-19 2023-02-01 The Coca-Cola Company Beverage comprising rebaudioside x
EP3009010A1 (en) 2011-12-19 2016-04-20 PureCircle SDN BHD Methods for purifying steviol glycosides and uses of the same
EP3345490A1 (en) 2011-12-19 2018-07-11 The Coca-Cola Company Beverage comprising rebaudioside x
EP3593649A1 (en) 2011-12-19 2020-01-15 PureCircle SDN BHD Methods for purifying steviol glycosides and uses of the same
EP3735841A1 (en) 2011-12-19 2020-11-11 PureCircle SDN BHD Methods for purifying steviol glycosides and uses of the same
US10711024B2 (en) 2014-12-17 2020-07-14 Cargill, Incorporated Steviol glycoside compounds, compositions for oral ingestion or use, and method for enhancing steviol glycoside solubility
US11407780B2 (en) 2014-12-17 2022-08-09 Cargill, Incorporated Steviol glycoside compounds, compositions for oral ingestion or use, and method for enhancing steviol glycoside solubility
US10906927B2 (en) 2014-12-17 2021-02-02 Cargill, Incorporated Steviol glycoside compounds, compositions for oral ingestion or use, and method for enhancing steviol glycoside solubility
US11344051B2 (en) 2015-04-03 2022-05-31 Dsm Ip Assets B.V. Steviol glycosides
US11540544B2 (en) 2015-04-03 2023-01-03 Dsm Ip Assets B.V. Steviol glycosides
EP4159050A1 (en) 2015-11-30 2023-04-05 Cargill, Incorporated Steviol glycoside compositions for oral ingestion or use

Also Published As

Publication number Publication date
AU4028300A (en) 2000-10-16
EP1164872A1 (en) 2002-01-02
WO2000057725A1 (en) 2000-10-05

Similar Documents

Publication Publication Date Title
US6365216B1 (en) Particles of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester
US6365217B2 (en) N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester agglomerate
EP2934193B1 (en) Co-crystallized sweeteners
RU2483584C2 (en) Natural highly efficient sweeteners composition delivery system and such systems production methods and application
JP4678949B2 (en) Co-crystal of sugar and N- [N- (3,3-dimethylbutyl) -1-α-aspartyl] -L-phenylalanine 1-methyl
US20020001652A1 (en) Process for making granulated N-[N- (3, 3-dimethylbutyl) -L-alpha -aspartyl] -L- phenylalanine 1-methyl ester
DK2328426T3 (en) COMPOSITIONS INCLUDING SWEET AMPLIFIERS AND PROCEDURES FOR PRODUCING THEREOF
EP3815540A1 (en) Sweetener powder composition and preparation method therefor
ZA200603125B (en) Process for preparing solidified maltitol and its use in food and pharma products
EP1576891A1 (en) Method for drying neotame with co-agents
WO2000015049A1 (en) THE USE OF CYCLODEXTRIN TO STABILIZE N-[N- (3,3-DIMETHYLBUTYL) -1-α- ASPARTYL] -L-PHENYLALANINE 1-METHYL ESTER
Favaro-Trindade et al. Microencapsulation of sweeteners
US20060083837A1 (en) Aspartame blend
WO2021054452A1 (en) Whey protein granulated material
WO2021054454A1 (en) Soy protein granulated material
JP5548506B2 (en) Composition containing neotame
JP2540685B2 (en) Fast-dissolving sweetener containing caramel
CN105722408A (en) High intensity sweetener composition
EP1301092A2 (en) Method of preparing liquid compositions for delivery of n- 3, 3-dimethylbutyl-l-alpha-aspartyl] -l-phenylalanine 1-methyl ester in food and beverage systems
MXPA00006092A (en) Sweetener composition

Legal Events

Date Code Title Description
AS Assignment

Owner name: NUTRASWEET COMPANY, THE, ILLINOIS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DRON, ADITI;BISHAY, IHAB E.;FOTOS, JIM;AND OTHERS;REEL/FRAME:010697/0834

Effective date: 20000321

AS Assignment

Owner name: BANKERS TRUST COMPANY, NEW YORK

Free format text: SECURITY INTEREST;ASSIGNOR:NUTRASWEET COMPANY, THE;REEL/FRAME:010919/0925

Effective date: 20000525

STCF Information on status: patent grant

Free format text: PATENTED CASE

AS Assignment

Owner name: NUTRASWEET COMPANY, THE, ILLINOIS

Free format text: RELEASE OF SECURITY INTEREST IN U.S. PATENTS;ASSIGNOR:DEUTSCHE BANK TRUST COMPANY AMERICAS (F/K/A BANKERS TRUST COMPANY), AS AGENT;REEL/FRAME:015246/0555

Effective date: 20041008

AS Assignment

Owner name: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT, CO

Free format text: SECURITY INTEREST;ASSIGNOR:NUTRASWEET COMPANY, THE;REEL/FRAME:015246/0841

Effective date: 20041008

Owner name: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT, CO

Free format text: SECURITY AGREEMENT;ASSIGNOR:NUTRASWEET COMPANY, THE;REEL/FRAME:015302/0536

Effective date: 20041008

AS Assignment

Owner name: GENERAL ELECTRIC CAPITAL CORPORATION AS SECOND LIE

Free format text: SECOND LIEN PATENT SECURITY AGREEMENT;ASSIGNOR:NUTRASWEET COMPANY, THE;REEL/FRAME:015377/0450

Effective date: 20041008

FPAY Fee payment

Year of fee payment: 4

AS Assignment

Owner name: NUTRASWEET COMPANY, THE, ILLINOIS

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION, AS SECOND LIEN AGENT;REEL/FRAME:021547/0082

Effective date: 20080828

Owner name: NUTRASWEET COMPANY, THE, ILLINOIS

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS RECORDED 10/15/2004 WITH USPTO AT REEL 015302 FRAME 0536.;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT;REEL/FRAME:021547/0105

Effective date: 20080828

AS Assignment

Owner name: BANK OF AMERICA, N.A., AS AGENT, GEORGIA

Free format text: SECURITY INTEREST;ASSIGNOR:NUTRASWEET COMPANY, THE;REEL/FRAME:021603/0108

Effective date: 20080828

AS Assignment

Owner name: BANK OF AMERICA, N.A., AGENT, NORTH CAROLINA

Free format text: COLLATERAL ASSIGNMENT OF PATENTS;ASSIGNOR:THE NUTRASWEET COMPANY;REEL/FRAME:021658/0803

Effective date: 20080828

FPAY Fee payment

Year of fee payment: 8

AS Assignment

Owner name: NUTRASWEET PROPERTY HOLDINGS, INC., ILLINOIS

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:THE NUTRASWEET COMPANY;REEL/FRAME:023427/0510

Effective date: 20090708

FPAY Fee payment

Year of fee payment: 12

AS Assignment

Owner name: THE NUTRASWEET COMPANY, GEORGIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:035147/0867

Effective date: 20150209